首页> 外文期刊>Microbiology >Identification of the immunoproteome of the meningococcus by cell surface immunoprecipitation and MS
【24h】

Identification of the immunoproteome of the meningococcus by cell surface immunoprecipitation and MS

机译:细胞表面免疫沉淀和MS鉴定脑膜炎球菌的免疫蛋白质

获取原文
           

摘要

Most healthy adults are protected from meningococcal disease by the presence of naturally acquired anti-meningococcal antibodies; however, the identity of the target antigens of this protective immunity remains unclear, particularly for protection against serogroup B disease. To identify the protein targets of natural protective immunity we developed an immunoprecipitation and proteomics approach to define the immunoproteome of the meningococcus. Sera from 10 healthy individuals showing serum bactericidal activity against both a meningococcal C strain (L91543) and the B strain MC58, together with commercially available pooled human sera, were used as probe antisera. Immunoprecipitation was performed with each serum sample and live cells from both meningococcal strains. Immunoprecipitated proteins were identified by MS. Analysis of the immunoproteome from each serum demonstrated both pan-reactive antigens that were recognized by most sera as well as subject-specific antigens. Most antigens were found in both meningococcal strains, but a few were strain-specific. Many of the immunoprecipitated proteins have been characterized previously as surface antigens, including adhesins and proteases, several of which have been recognized as vaccine candidate antigens, e.g. factor H-binding protein, NadA and neisserial heparin-binding antigen. The data demonstrate clearly the presence of meningococcal antibodies in healthy individuals with no history of meningococcal infection and a wide diversity of immune responses. The identification of the immunoreactive proteins of the meningococcus provides a basis for understanding the role of each antigen in the natural immunity associated with carriage and may help to design vaccination strategies.
机译:通过天然获得的抗脑膜炎球菌抗体存在,大多数健康的成年人受到脑膜炎球菌疾病的保护;然而,这种保护性抗扰度的靶抗原的身份仍不清楚,特别是对血群B疾病的保护。为了鉴定天然保护性免疫的蛋白质靶标,我们开发了一种免疫沉淀和蛋白质组学方法来定义脑膜炎球菌的免疫蛋白蛋白。来自10个健康个体的血清显示脑膜炎球菌C菌株(L91543)和B株MC58与市售合并的人类血清一起使用作为探针抗血清的血清杀菌活性。用来自脑膜炎球菌菌株的每个血清样品和活细胞进行免疫沉淀。通过MS鉴定免疫沉淀的蛋白质。从每种血清的免疫蛋白质分析显示了由大多数血清和对象特异性抗原识别的泛反应性抗原。大多数抗原在脑膜炎球菌菌株中发现,但少数是菌株特异性的。许多免疫沉淀的蛋白质以前作为表面抗原的特征,包括粘附素和蛋白酶,其中一些已被认​​为是疫苗候选抗原,例如疫苗候选抗原。因子H结合蛋白,NADA和Neisserial肝素结合抗原。该数据清楚地证明了脑膜炎球菌在健康个体中的存在,没有脑膜炎球菌感染的历史和广泛的免疫应答。脑膜炎球菌的免疫反应性蛋白质的鉴定为理解每种抗原在与运输相关的自然免疫中的作用提供依据,并有助于设计疫苗接种策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号